Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1702475

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1702475

Mineral Supplements Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

PUBLISHED:
PAGES: 330 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The global mineral supplements market is poised for significant growth, projected to rise from USD 16.8 billion in 2024 to USD 26.9 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.2%. This growth is driven by increasing adoption of supplements for preventing chronic diseases such as osteoporosis, anemia, and cancer, alongside the rise in lifestyle-associated disorders. The growing emphasis on preventive healthcare and the widespread use of mineral supplements for maintaining health are expected to propel the market.

The increasing prevalence of health conditions that result from nutritional deficiencies, along with the rising geriatric population, are also contributing to market growth. As aging populations experience difficulties in absorbing minerals through diet, there is an increased reliance on supplements. This trend, coupled with growing health awareness and disposable incomes, is fueling the demand for mineral supplements globally.

Key Insights

A key driver for the market is the growing demand for supplements that support bone health. Calcium supplements, in particular, account for the largest share of the market due to the rising incidence of osteoporosis, particularly among older adults and women. Calcium plays a crucial role in maintaining bone density and muscle function, making it essential in combating conditions like osteoporosis.

Another significant trend is the rising demand for potassium supplements, which are expected to record the highest CAGR during the forecast period. Potassium plays a vital role in fluid balance, muscle contraction, and nerve impulse transmission. It is also essential for preventing conditions like high blood pressure and cardiovascular diseases. With growing awareness of potassium's benefits, demand is surging, particularly among those concerned about hypertension and kidney health.

The increasing focus on plant-based and organic supplements also presents opportunities for market growth. Consumers are becoming more health-conscious and are opting for plant-derived, non-GMO products. This trend is particularly prominent in regions like North America and Europe, where demand for clean-label, organic, and sustainable products is strong.

The growing geriatric population is another major factor driving the demand for mineral supplements. As people age, their ability to absorb nutrients diminishes, leading to deficiencies in key minerals like calcium, magnesium, and iron. The World Health Organization (WHO) predicts that the global population aged 60 and above will reach 2.1 billion by 2050, up from 1 billion in 2020. As the elderly population increases, so does their need for supplements to maintain bone health, improve immunity, and enhance muscle function.

Challenges and Opportunities

While the mineral supplements market is growing, it faces challenges such as high production costs and the need for greater consumer education on the benefits of specific minerals. Market players are addressing these challenges by focusing on research and development (R&D) to create more effective and targeted supplements. Personalized supplements based on individual health needs are an emerging trend. This could be a major opportunity for the market, as consumers seek tailored solutions to address their unique health concerns.

Product Code: 10203

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by formulation
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by application
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2019-2030)
  • 6.3. Market Revenue, by Formulation (2019-2030)
  • 6.4. Market Revenue, by End User (2019-2030)
  • 6.5. Market Revenue, by Application (2019-2030)
  • 6.6. Market Revenue, by Region (2019-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2019-2030)
  • 7.3. Market Revenue, by Formulation (2019-2030)
  • 7.4. Market Revenue, by End User (2019-2030)
  • 7.5. Market Revenue, by Application (2019-2030)
  • 7.6. Market Revenue, by Country (2019-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2019-2030)
  • 8.3. Market Revenue, by Formulation (2019-2030)
  • 8.4. Market Revenue, by End User (2019-2030)
  • 8.5. Market Revenue, by Application (2019-2030)
  • 8.6. Market Revenue, by Country (2019-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2019-2030)
  • 9.3. Market Revenue, by Formulation (2019-2030)
  • 9.4. Market Revenue, by End User (2019-2030)
  • 9.5. Market Revenue, by Application (2019-2030)
  • 9.6. Market Revenue, by Country (2019-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2019-2030)
  • 10.3. Market Revenue, by Formulation (2019-2030)
  • 10.4. Market Revenue, by End User (2019-2030)
  • 10.5. Market Revenue, by Application (2019-2030)
  • 10.6. Market Revenue, by Country (2019-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2019-2030)
  • 11.3. Market Revenue, by Formulation (2019-2030)
  • 11.4. Market Revenue, by End User (2019-2030)
  • 11.5. Market Revenue, by Application (2019-2030)
  • 11.6. Market Revenue, by Country (2019-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2019-2030)
  • 12.3. Market Revenue, by Formulation (2019-2030)
  • 12.4. Market Revenue, by End User (2019-2030)
  • 12.5. Market Revenue, by Application (2019-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2019-2030)
  • 13.3. Market Revenue, by Formulation (2019-2030)
  • 13.4. Market Revenue, by End User (2019-2030)
  • 13.5. Market Revenue, by Application (2019-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2019-2030)
  • 14.3. Market Revenue, by Formulation (2019-2030)
  • 14.4. Market Revenue, by End User (2019-2030)
  • 14.5. Market Revenue, by Application (2019-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2019-2030)
  • 15.3. Market Revenue, by Formulation (2019-2030)
  • 15.4. Market Revenue, by End User (2019-2030)
  • 15.5. Market Revenue, by Application (2019-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2019-2030)
  • 16.3. Market Revenue, by Formulation (2019-2030)
  • 16.4. Market Revenue, by End User (2019-2030)
  • 16.5. Market Revenue, by Application (2019-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2019-2030)
  • 17.3. Market Revenue, by Formulation (2019-2030)
  • 17.4. Market Revenue, by End User (2019-2030)
  • 17.5. Market Revenue, by Application (2019-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2019-2030)
  • 18.3. Market Revenue, by Formulation (2019-2030)
  • 18.4. Market Revenue, by End User (2019-2030)
  • 18.5. Market Revenue, by Application (2019-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2019-2030)
  • 19.3. Market Revenue, by Formulation (2019-2030)
  • 19.4. Market Revenue, by End User (2019-2030)
  • 19.5. Market Revenue, by Application (2019-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2019-2030)
  • 20.3. Market Revenue, by Formulation (2019-2030)
  • 20.4. Market Revenue, by End User (2019-2030)
  • 20.5. Market Revenue, by Application (2019-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2019-2030)
  • 21.3. Market Revenue, by Formulation (2019-2030)
  • 21.4. Market Revenue, by End User (2019-2030)
  • 21.5. Market Revenue, by Application (2019-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2019-2030)
  • 22.3. Market Revenue, by Formulation (2019-2030)
  • 22.4. Market Revenue, by End User (2019-2030)
  • 22.5. Market Revenue, by Application (2019-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2019-2030)
  • 23.3. Market Revenue, by Formulation (2019-2030)
  • 23.4. Market Revenue, by End User (2019-2030)
  • 23.5. Market Revenue, by Application (2019-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2019-2030)
  • 24.3. Market Revenue, by Formulation (2019-2030)
  • 24.4. Market Revenue, by End User (2019-2030)
  • 24.5. Market Revenue, by Application (2019-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2019-2030)
  • 25.3. Market Revenue, by Formulation (2019-2030)
  • 25.4. Market Revenue, by End User (2019-2030)
  • 25.5. Market Revenue, by Application (2019-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2019-2030)
  • 26.3. Market Revenue, by Formulation (2019-2030)
  • 26.4. Market Revenue, by End User (2019-2030)
  • 26.5. Market Revenue, by Application (2019-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2019-2030)
  • 27.3. Market Revenue, by Formulation (2019-2030)
  • 27.4. Market Revenue, by End User (2019-2030)
  • 27.5. Market Revenue, by Application (2019-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2019-2030)
  • 28.3. Market Revenue, by Formulation (2019-2030)
  • 28.4. Market Revenue, by End User (2019-2030)
  • 28.5. Market Revenue, by Application (2019-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Glanbia PLC
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Abbott Laboratories
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Nestle S.A.
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Biovea
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
    • 30.4.4. Herbalife International of America, Inc.
    • 30.4.5. Business overview
    • 30.4.6. Product and service offerings
    • 30.4.7. Key financial summary
  • 30.5. Sanofi
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Amway
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Bayer AG
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Omega Protein Corporation
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Bio Botanica Inc.
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!